Taste Properties of Atazanavir and Cobicistat

• Status: Unknown status
• Trial end date: 2020-04-21
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective is to assess the taste properties of atazanavir (ATV) and cobicistat (COBI) alone and in combination as well as oral test formulations containing both ATV and COBI.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Atazanavir Sulfate; Cobicistat

Criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

• Men and women, ages ≥18 years

• Subjects who are qualified professional sensory panelists

• Healthy subjects as determined by no clinically significant deviation from normal in medical history and physical assessment

Exclusion Criteria:

• Any acute or chronic condition that may alter taste or smell sensory perception

• Any significant acute or chronic medical illness or any surgery within 4 weeks of the study drug administration

• Positive HIV test using an oral swab kit (such as OraQuick®) to detect HIV-1 or -2 antibody